Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Adcock Richard, Chairman & CEO. Director active across 1 company, notably ImmunityBio, Inc.. Cumulatively, 16 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €54. History available since 9 September 2021. The latest transaction was filed on 22 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Adcock Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Adcock Richard is Président-Directeur Général and at ImmunityBio, Inc. (XNAS) serves as CEO & President. He has 16 filings in total, and across the recent filings tracked, the period runs from 2021-09-13 to 2026-02-24, with buy volume of EUR 54 and no sell volume, and the most common transaction nature is option exercise.